1. | nahi2 | |
2. | healthandliving2 | |
3. | petalite | |
4. | AaronFrasier | |
5. | ekfrance |
1. | nahi2 | |
2. | healthandliving2 | |
3. | petalite | |
4. | AaronFrasier | |
5. | ekfrance |
1. | nahi2 03/09/2018 Genomic Health Announces 2017 Fourth Quarter and Year-end Financial Results, Provides 2018 Financial Outlook |
2. | healthandliving2 06/03/2018 Landmark TAILORx Results, Published Today in The New England Journal of Medicine, Demonstrate the Oncotype DX Breast Recurrence Score® Test Definitively Identifies the 70% of Women with Early-stage Br |
3. | AaronFrasier 12/14/2017 That is big news! |
4. | bernardlbrown 04/02/2018 Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX® AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic |
5. | nahi2 02/05/2018 Announces publication of 'evidence demonstrating |
6. | petalite 06/04/2018 Genomic Health landmark TAILORx results, published today in the New England Journal of Medicine |
7. | petalite 05/21/2018 Announces results from two new studies |
8. | healthandliving2 03/30/2018 Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX® AR-V7 Nucleus Detect™ Test in Patients with Metastatic Cas |
9. | nahi2 12/14/2017 Genomic Health (GHDX) Oncotype DX Score Test Data Positive |